We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
首个成功的体内基因编辑三期试验：lonvo-z疗法将HAE发作减少87%。了解这一突破及预防性治疗的终止。
